David Mountcastle Sells 21,275 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 21,275 shares of the business’s stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total transaction of $588,679.25. Following the completion of the sale, the chief financial officer owned 164,853 shares of the company’s stock, valued at approximately $4,561,482.51. The trade was a 11.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Tuesday, July 7th, David Mountcastle sold 600 shares of Privia Health Group stock. The shares were sold at an average price of $27.57, for a total transaction of $16,542.00.
• On Thursday, July 2nd, David Mountcastle sold 24,734 shares of Privia Health Group stock. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00.
• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The stock was sold at an average price of $25.18, for a total value of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The stock was sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Price Performance

Privia Health Group stock opened at $28.03 on Wednesday. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 175.20, a price-to-earnings-growth ratio of 2.21 and a beta of 0.83. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $28.30. The stock’s 50-day moving average is $23.90 and its 200-day moving average is $23.19.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on PRVA. Canaccord Genuity Group reduced their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Barclays dropped their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Finally, Zacks Research downgraded Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average price target of $31.15.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in PRVA. ArrowMark Colorado Holdings LLC acquired a new stake in Privia Health Group during the third quarter valued at approximately $8,750,000. Renaissance Group LLC acquired a new position in shares of Privia Health Group in the 4th quarter worth approximately $7,776,000. Principal Financial Group Inc. grew its position in shares of Privia Health Group by 1.6% in the 4th quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after acquiring an additional 43,589 shares in the last quarter. Algert Global LLC increased its holdings in shares of Privia Health Group by 277.4% in the 3rd quarter. Algert Global LLC now owns 484,304 shares of the company’s stock valued at $12,059,000 after acquiring an additional 355,966 shares during the last quarter. Finally, Louisiana State Employees Retirement System bought a new stake in shares of Privia Health Group in the 1st quarter valued at approximately $1,055,000. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.